Mutation of the 9q34 gene TSC1 in sporadic bladder cancer.
Deletions involving chromosome 9 occur in more than 50% of human bladder cancers of all grades and stages. Most involve loss of the whole chromosome or of an entire chromosome arm but some small deletions are found which can be used to define critical regions which may contain tumour suppressor genes. We have localized such a critical region of deletion at 9q34 between the markers D9S149 and D9S66, an interval which contains the Tuberous Sclerosis gene TSC1. Single strand conformation polymorphism (SSCP) and sequence analysis of TSC1 in bladder tumours and cell lines with 9q34 loss of heterozygosity (LOH) has identified five mutations in retained TSC1 alleles. Our results support the hypothesis that TSC1 can act as a bladder tumour suppressor gene.
Hornigold
N
N
ICRF Cancer Medicine Research Unit, St. James's University Hospital, Leeds, UK.
Devlin
J
J
Davies
A M
AM
Aveyard
J S
JS
Habuchi
T
T
Knowles
M A
MA
D002899:Chromosomes, Human, Pair 9; D017931:DNA Primers; D005091:Exons; D005799:Genes, Dominant; D016147:Genes, Tumor Suppressor; D008040:Genetic Linkage; D006801:Humans; D019656:Loss of Heterozygosity; D008957:Models, Genetic; D009154:Mutation; D018807:Polymorphism, Single-Stranded Conformational; D011506:Proteins / Q000235:genetics*; D017384:Sequence Deletion; D000077004:Tuberous Sclerosis Complex 1 Protein; D025521:Tumor Suppressor Proteins; D001749:Urinary Bladder Neoplasms / Q000235:genetics*
D017931:DNA Primers; D011506:Proteins; C000624650:TSC1 protein, human; D000077004:Tuberous Sclerosis Complex 1 Protein; D025521:Tumor Suppressor Proteins